APPLIED BIOLOGICAL LABORATORIES, INC.
Topical antiviral treatments combining viral inhibitors with innate immune factors to treat rhinovirus and influenza infections
- Sector
- Biotech
- Headquarters
- NEW YORK, NY
- Founded
- 2016
- Latest Form D
- $1M, May 2016
- Total capital
- $1.2M
- Federal grants
- $224K
- 1 award · 2019
- Rank in peer group#321 of 392
- Private capital raised
- $1M
- 1 Form D · last May 2016
- 125 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 10 pending · first 2025
- Rank in peer group#40 of 392
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Novel Anti-Viral Formulation to Prevent Rhinovirus and Influenza$224K
- Private capital raisedForm D · SEC · 1st filing$1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#40 · top 10%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Nazlie LatefiResearcherExecutive Officer, DirectorLinked by 3 patents · $224K in grants as PI
- Michael LatefiExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 13- GrantedCompositions And Methods For Protecting Against Airborne Pathogens And IrritantsUSPTOUS 12,594,285
- GrantedCompositions And Methods For Protecting Against Airborne Pathogens And IrritantsUSPTOUS 12,447,166
- GrantedCompositions And Methods For Protecting Against Airborne Pathogens And IrritantsUSPTOUS 12,447,200
Show all 13 patent records
- Compositions And Methods For Protecting Against Airborne Pathogens And IrritantsApr 7, 2026 · US 12,594,285Granted
- Compositions And Methods For Protecting Against Airborne Pathogens And IrritantsOct 21, 2025 · US 12,447,166Granted
- Compositions And Methods For Protecting Against Airborne Pathogens And IrritantsOct 21, 2025 · US 12,447,200Granted
- Compositions And Methods Using Non-steroidal Anti-inflammatory DrugsOct 6, 2022 · Application 17637372Pending
- Compositions And Methods For Protecting Against Airborne Pathogens And IrritantsFeb 25, 2021 · Application 17092184Pending
- Compositions And Methods For Protecting Against Pathogens And IrritantsApplication PCTUS2018048985Pending
- Compositions And Methods For Protecting Against Airborne Pathogens And IrritantsApplication PCTUS2018048544Pending
- Compositions And Methods For Protecting Against Pathogens And IrritantsApplication 62552348Pending
- Compositions And Methods For Protecting Against Airborne Pathogens And IrritantsApplication PCTUS2017019535Pending
- Glycyrrhizin For The Treatment Or Prophylaxis Of Viral InfectionApplication PCTUS2021048945Pending
- Glycyrrhizin For The Treatment Or Prophylaxis Of Viral InfectionApplication 63073859Pending
- Compositions And Methods Using Non-steroidal Anti-inflammatory DrugsApplication PCTUS2020047551Pending
- Compositions And Methods Using Non-steroidal Anti-inflammatory DrugsApplication 62890517Pending
Related companies, and why
- Lipomedics Inc.Similar federal contract value in Biotech · null in contracts
- NAVEGA THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- PAIN THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- METANOIA BIO LLCSimilar federal contract value in Biotech · null in contracts
- THENDOR THERAPEUTICS LLCSimilar federal contract value in Biotech · null in contracts
- EPIVARIO INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .